Cationic Zirconocene and Hafnocene Aryl Complexes
Organometallics, Vol. 26, No. 19, 2007 4753
matched calculated isotope patterns. The listed m/z value corre-
sponds to the most intense peak in the isotope pattern.
Cp′ Me). 13C{gated-1H} (CD2Cl2, -89 °C): δ 183.9 (s, ipso-Ph),
135.6 (d, J ) 153, o-Ph), 125.6 (d, J ) 157, m-Ph), 124.5 (d, J )
160, p-Ph), 123.4 (s, Cp′ ipso), 113.5 (d, J ) 170, Cp′ CH), 110.2
(d, J ) 172, Cp′ CH), 14.7 (q, J ) 128, Cp′ Me).
Complexes 2a-g were shielded from light when handled in
solution, and CD2Cl2 solutions of 2a-e were freshly made and kept
at temperatures below -60 °C.
1
Cp2Hf(o-tolyl)2 (1f). H NMR (C6D5Cl, 23 °C): δ 7.16 (br s,
Cp2Zr(o-tolyl)2 (1a). 1H NMR (CD2Cl2): δ 7.15 (d, J ) 7, 2H,
H3 or H6), 7.05 (d, J ) 7, 2H, H3 or H6), 6.96 (m, 4H, H4 and
2H, H3 or H6), 7.12 (br d, J ) 7.0, 2H, H3 or H6), 7.08 (t, J )
7.3, 2H, H4 or H5), 7.02 (t, J ) 7.5, 2H, H4 or H5), 5.85 (br s,
10H, Cp), 2.19 (br s, 6H, Me). 13C{1H} NMR (C6D5Cl, 23 °C): δ
190.9 (C1), 146.5 (C2), 133.0 (C6; JCH ) 148 Hz from 13C{gated-
1H} spectrum at 90 °C), 130.5 (C3), 127.8 (C4), 125.6 (C5), 111.0
(Cp), 26.5 (Me). All of the 13C signals are broad due to restricted
rotation of the o-tolyl groups.
Cp2HfPh2 (1g). 1H NMR (C6D5Cl, 23 °C): δ 7.35 (d, J ) 7.2,
4H, o-Ph), 7.23 (t, J ) 7.4, 4H, m-Ph), 7.06 (t, J ) 7.3, 2H, p-Ph),
5.89 (s, 10H, Cp). 13C{gated-1H} NMR (C6D5Cl, 23 °C): δ 191.9
(s, ipso-Ph), 137.6 (d, J ) 155, o-Ph), 127.2 (d, J ) 161, m-Ph),
125.3 (d, J ) 163, p-Ph), 111.9 (d, J ) 177, Cp).
1
H5), 6.12 (s, 10H, Cp), 2.35 (s, 6H, Me). H NMR (C6D5Cl) key
data: δ 7.2 (m, H3 and H6, 2H), 6.82 (s, 10H, Cp). 13C{gated-1H}
NMR (CD2Cl2, -89 °C): δ 182.1 (s, C1), 145.9 (s, C2), 129.0 (d,
J ) 152, C6), 128.4 (d, J ) 154), 124.7 (d, J ) 159), 122.3 (d, J
) 160), 110.3 (d, J ) 174, Cp), 25.4 (q, J ) 125, Me). 13C{gated-
1H} NMR (C6D5Cl) key data: δ 129.6 (d, J ) 152, C6), 111.8
(d, J ) 173, Cp).
Cp2Zr(2-Me-4-F-C6H3)2 (1b). A flask was charged with 2-bromo-
5-fluorotoluene (1.05 g, 5.53 mmol), and a sidearm addition tube
containing Cp2ZrCl2 (0.812 g, 2.78 mmol) was attached. Diethyl
ether (20 mL) was added, the solution was stirred at 23 °C, and
nBuLi (2.1 mL, 2.68 M in hexane, 5.63 mmol) was added dropwise.
After 30 min, the Cp2ZrCl2 was added slowly to the pale yellow
solution and the mixture was stirred for 1.5 h. The solvent was
removed under vacuum, yielding a yellow-white solid. This material
was taken up in toluene (ca. 10 mL) and filtered to give a yellow
filtrate. The filtrate was concentrated under vacuum until the
saturation point was reached. Hexane was layered onto the solution,
precipitating a white microcrystalline solid. A second recrystalli-
zation using the same procedure yielded analytically pure product
(0.18 g, 15%). 1H NMR (CD2Cl2, 23 °C): δ 7.02 (dd, 3JHH ) 8.2,
[Cp2Zr(o-tolyl)][B(C6F5)4] (2a). A chlorobenzene solution
(3 mL) of Cp2Zr(o-tolyl)2 (100 mg, 0.248 mmol) and Cp2ZrMe2
(62.3 mg, 0.248 mmol) was added dropwise to a chlorobenzene
solution (5 mL) of [Ph3C][B(C6F5)4] (457 mg, 0.495 mmol) in the
dark. The mixture was stirred for 30 min at 23 °C. The volatiles
were removed under vacuum, and the resulting orange oil was
washed with benzene (3 × 5 mL) to remove triphenylethane. The
orange oil was dried under vacuum, yielding [Cp2Zr(o-tolyl)]-
[B(C6F5)4]‚(C6H6)1.5 as an orange solid (0.28 g, 53%). The benzene
content was determined by NMR. 1H NMR (CD2Cl2, -89 °C): δ
7.35 (t, J ) 7.5, 1H, aryl), 7.19 (m, 2H, aryl), 6.27 (s, 10H, Cp),
3
4
1
4JHF ) 7.2, 2H, H6), 6.78 (dd, JHF ) 11.5, JHH ) 2.3, 2H, H3),
6.02 (d, J ) 7.3, 1H, H6), 2.32 (s, 3H, Me). H NMR (C6D5Cl)
3
3
4
6.67 (ddd, JHF ) 9.2, JHH ) 8.2, JHH ) 2.5, 2H, H5), 6.14 (s,
key data: δ 5.9 (d, J ) 7, 1H, H6), 5.74 (s, 10H, Cp). 13C{gated-
1H} NMR (CD2Cl2, -89 °C): δ 192.3 (s, C1), 145.2 (s, C2), 130.6
(d, J ) 159), 128.9 (d, J ) 159), 126.6 (poorly resolved d, C5),
112.6 (d, J ) 177, Cp), 93.8 (dd, J ) 124, 9, C6), 22.8 (qd, J )
125, 4, Me). 13C{gated-1H} NMR (C6D5Cl) key data: δ 113.5 (d,
J ) 76, Cp), 95.9 (dd, J ) 125, 10; C6). A sample of 2a for
elemental analysis was further dried under vacuum for 3 days,
yielding material containing 0.7 equiv of C6H6 as determined by
NMR. Anal. Calcd for C41H17BF20Zr‚(C6H6)0.7: C, 51.79; H, 2.03.
Found: C, 51.82; H, 2.31.
10H, Cp), 2.30 (s, 6H, Me). 13C{1H} NMR (CD2Cl2, 23 °C): δ
1
175.8 (s, C1), 162.3 (d, JCF ) 243, C4), 148.4 (br s, C2), 131.3
(br s, C6), 116.1 (d, 2JCF ) 16, C3 or C5), 111.7 (br s, Cp), 109.8
(d, JCF ) 18, C5 or C3), 26.1 (s, Me). 19F{1H} NMR (CD2Cl2,
2
23 °C): δ -119.2 (s). Anal. Calcd for C24H22F2Zr: C, 65.56; H,
5.04. Found: C, 65.29; H, 5.04.
Cp2Zr(3-F-C6H4)2 (1c). A flask was charged with a THF
solution of 3-fluorophenylmagnesium bromide (15.0 mL, 7.50
mmol). The solvent was removed under vacuum to afford a colorless
oil, and Cp2ZrCl2 (1.05 g, 3.59 mmol) was added. Diethyl ether
(20 mL) was added by vacuum transfer, and the mixture was stirred
for 2 h at room temperature, producing a suspension of a white
precipitate in a pale yellow supernatant. The volatiles were removed
under vacuum, and the white solid was triturated with hexane (ca.
15 mL). The solid was taken up in toluene and filtered, and the
filtrate was concentrated under vacuum. The concentrated solution
was layered with hexane at -35 °C, yielding 1c as a white,
[Cp2Zr(2-Me-4-F-C6H3)][B(C6F5)4] (2b). This compound was
prepared from Cp2Zr(2-Me-4-F-C6H3)2 (150 mg, 0.341 mmol), Cp2-
ZrMe2 (85.8 mg, 0.341 mmol), and [Ph3C][B(C6F5)4] (629 mg,
0.682 mmol) using the procedure for 2a. The orange oil was dried
under vacuum, yielding [Cp2Zr(2-Me-4-F-C6H3)][B(C6F5)4]‚(C6H6)1.8
1
as an orange solid (0.54 g, 34%). H NMR (CD2Cl2, -89 °C): δ
6.97 (m, 2H, H3 and H4), 6.31 (s, 10H, Cp), 5.96 (dd, 3JHH ) 7.8,
4JHF ) 4.0, 1H, H6), 2.32 (s, 3H, Me). 13C{gated-1H} NMR (CD2-
1
1
microcrystalline solid (0.35 g, 24%). H NMR (CD2Cl2): δ 7.12
Cl2, -89 °C): δ 186.3 (s, C1), 162.5 (d, JCF ) 247, C4), 147.8
3
4
(td, JHH ) 8, JHF ) 6, 2H, H5), 6.96 (m, 4H, H2 and H6), 6.71
(t, 3JHF ) 9, 3JHH ) 8, 2H, H4), 6.22 (s, 10H, Cp). 13C{gated-1H}
(CD2Cl2, -89 °C): δ 184.8 (s, C1), 160.8 (1JCF ) 249, C3), 130.2
(d, 3JCF ) 6, C2), 118.1 (dd, 1JCH ) 156, 2JCF ) 20, C3), 113.0 (d,
1JCH ) 176, Cp), 112.1 (dd, 1JCH ) 162, 2JCF ) 21, C5), 97.7 (dd,
3
1
1JCH ) 129, JCF ) 10, C6), 23.0 (q, JCH ) 127, Me). 19F{1H}
1
4
1
3
(dd, JCH ) 157, JCF ) 3, C6), 127.1 (dd, JCH ) 161, JCF ) 5,
C5), 121.8 (dd, 1JCH ) 159, 2JCF ) 15, C2), 112.3 (d, 1JCH ) 174,
(CD2Cl2, -89 °C): δ -114.6 (s).
[Cp2Zr(3-F-C6H4)][B(C6F5)4] (2c). This compound was prepared
from Cp2Zr(2-F-C6H4)2 (0.100 g, 0.243 mmol), Cp2ZrMe2 (0.061
g, 0.243 mmol), and [Ph3C][B(C6F5)4] (0.448 g, 0.486 mmol) using
the procedure for 2a. The orange oil was dried under vacuum,
yielding [Cp2Zr(3-F-C6H4][B(C6F5)4]‚(C6H6)1.5 as an orange solid
(0.24 g, 43%). 1H NMR (CD2Cl2, -89 °C): δ 7.40 (td, 3JHH ) 8,
Cp), 111.3 (dd, JCH ) 165, JCF ) 21, C4). The 1H and 13C
assignments were confirmed by HMQC. 19F{1H} (CD2Cl2,
-89 °C): δ -116.3 (s).
1
2
1
Cp2ZrPh2 (1d). H NMR (CD2Cl2, -89 °C): δ 7.20 (d, J )
6.6, 4H, o-Ph), 7.05 (t, J ) 7.2, 4H, m-Ph), 6.96 (t, J ) 6.2, 2H,
1
3
3
p-Ph), 6.17 (s, 10H, Cp). H NMR (C6D5Cl): δ 7.30 (d, J ) 7.2,
4JHF ) 5, 1H, H5), 7.19 (d, JHF ) 7, 1H, H2), 6.93 (td, JHH
)
4H, o-Ph), 7.17 (t, J ) 7.3, 4H, m-Ph), 7.07 (t, J ) 6.6, 2H, p-Ph),
5.91 (s, 10H, Cp). 13C{gated-1H} (CD2Cl2, -89 °C): δ 182.2 (ipso-
Ph), 135.5 (d, J ) 156, o-Ph), 125.8 (d, J ) 160, m-Ph), 124.6 (d,
J ) 159, p-Ph), 111.9 (d, J ) 174, Cp). 13C{1H} (C6D5Cl): δ 183.1
(ipso-Ph), 135.8 (o-Ph), 126.8 (m-Ph), 125.5 (p-Ph), 112.2 (Cp).
3JHF ) 8, 4JHH ) 2, 1H, H4), 6.42 (s, 10H, Cp), 6.37 (d, 3JHH ) 8,
1H, H6). 13C{gated-1H} (CD2Cl2, -89 °C): δ 193.4 (s, C1), 162.4
1
1
3
(d, JCF ) 256, C3), 130.3 (dd, JCH ) 164, JCF ) 6, C5), 120.2
(dd, 1JCH ) 163, 2JCF ) 18, C2), 115.6 (dd, 1JCH ) 165, 2JCF ) 23,
C4), 114.4 (d, 1JCH ) 176, Cp), 105.7 (d, 1JCH ) 141, C6). 19F{1H}
(CD2Cl2, -89 °C): δ -112.0 (s).
1
Cp′2ZrPh2 (1e). H NMR (CD2Cl2, -89 °C): δ 7.27 (d, J )
6.7, 4H, o-Ph), 7.10 (t, J ) 7.2, 4H, m-Ph), 7.02 (t, J ) 7.1, 2H,
p-Ph), 6.15 (m, 4H, Cp′ CH), 5.91 (m, 4H, Cp′ CH), 1.69 (s, 6H,
[Cp2ZrPh][B(C6F5)4] (2d). This compound was prepared from
Cp2ZrPh2 (74.9 mg, 0.199 mmol), Cp2ZrMe2 (50.1 mg, 0.199